Acquired Angioedema Due to C1 inhibitor Deficiency Caused by Non-Hodgkin Lymphoma in a Patient with Myasthenia Gravis Cover

.blurhash-client-img { display: none !important; }

Acquired Angioedema Due to C1 inhibitor Deficiency Caused by Non-Hodgkin Lymphoma in a Patient with Myasthenia Gravis

Revista Romana de Medicina de Laborator

Volume 29 (2021): Issue 4 (October 2021)

By: Noémi Bara, Valentin Nadasan, Lilian Varga and Henriette Farkas

Open Access

|Oct 2021

Authors

Noémi Bara

Romanian Hereditary Angioedema Expertise Centre, Sangeorgiu de Mures, Romania

Valentin Nadasan

valentin.nadasan@umfst.ro

Romanian Hereditary Angioedema Expertise Centre, Sangeorgiu de Mures, Romania

Hygiene Department, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania

Lilian Varga

Hungarian Angioedema Center of Reference and Excellence, Budapest, Hungary

Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary

Henriette Farkas

Hungarian Angioedema Center of Reference and Excellence, Budapest, Hungary

Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary

DOI: https://doi.org/10.2478/rrlm-2021-0029 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624

Journal RSS Feed

Language: English

Page range: 453 - 456

Submitted on: Sep 7, 2021

|

Accepted on: Sep 23, 2021

|

Published on: Oct 22, 2021

Published by: Romanian Association of Laboratory Medicine

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

bradykinin mediated angioedema,

lymphoproliferative disease,

autoimmune disease,

angioedema attack

Related subjects:

Molecular biology,

Microbiology and virology

© 2021 Noémi Bara, Valentin Nadasan, Lilian Varga, Henriette Farkas, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 29 (2021): Issue 4 (October 2021)